Founded in 1998, AllCells is a biotechnology company dedicated to providing global researchers and biomanufacturing organizations with a dependable supply of biologically relevant, high quality primary cells that enable drug discovery, development, and manufacturing of cell therapies. Leveraging its expertise in hematology and immunology cell isolations, combined with on-site whole blood and bone marrow tissue collection operations, AllCells maintains direct access to a large repository of diverse donor profiles that can be further screened and qualified for biomedical applications. Utilizing its contiguous cell processing facilities, freshly collected tissue is immediately processed into purified cell types with unparalleled quality consistency. This optimal work-flow provides for the highest viability, purity, and cell count available. Fresh or frozen cells are shipped worldwide, or fresh cells can be immediately utilized in fee-for-service cell-based assays, AllCellutions™ – delivering cell culture results/data to meet client project timelines.
AllCells is grateful to our customers for their support over the past 19 years! We have grown by adapting to changing market trends to ensure we are anticipating and enhancing our offerings to our customers around the world. We are pleased to continue fulfilling your special requirements and look forward to working with you in the future!
The story of AllCells begins with our Founder and President, Dr. Jay Tong. After completing his training as a hematologist, Dr. Tong began a career as a research scientist in the early 90’s. While working at Novartis Systemics, he noticed a common pain-point amongst his peers: how to get starting materials for their projects? Many of them resorted to donating themselves or asking friends and family. Even with these substitutes they were never sure if they could get enough samples by the end of the day for their experiments. “Why is this such a frustrating process? Are there any commercial entities to help?” thought Dr. Tong. Before the time of internet searches, Dr. Tong asked around from colleagues and determining that no commercial sources existed, decided to do it himself. Read the full story here.
The AllCells AAA Guarantee covers all the different ways you may customize your order with us by:
- Always guaranteeing cell viability and quantity meet its product specifications
- Always guaranteeing cell purity meets it’s product specification
- Always guaranteeing customized orders are delivered as promised and specified by customers
We love feedback from our customers! If our products/services have helped your experiments please share your story with us and let us know how we can better serve your needs in the future.
Jay Tong, M.D, founded AllCells, LLC in 1998 and has served as the company’s President & CEO since that time. While working as a Research Scientist at Novartis-Systemix (Palo Alto, CA) in the 1990s, Dr. Tong recognized an industry need for a readily available commercial source of hematologic tissue such as bone marrow, cord & peripheral blood, and purified hematology & immunology primary cell types needed to support scientific research, drug discovery and development.
Wayne Vaz, Vice President, Corporate Development, joined AllCells, LLC, in 2010 as a member of the executive team, responsible for commercial strategy and transforming the company into a market leader. Mr. Vaz has held executive positions in Canada and U.S covering areas of corporate business development, technology & alliance, technology roadmapping, strategic planning, M&A, market channel development, technical services, and quality assurance.
Rob Frankenberg joined AllCells’ executive team June 20, 2016 as Vice President of Manufacturing Operations. Previously Rob was GMP Operations Manager at Bio-Rad Laboratories, Hercules, accountable for the operational leadership of Bio-Rad’s Northern California GMP clinical diagnostics consumables manufacturing operation representing >$250M in annual sales and a production team of 29 team members and 3 supervisors.
Tim Fong joined the executive team March 16, 2017. Tim has over 20 years of biotech industry experience with broad expertise in therapeutic drug discovery and development. Tim has led teams in discovery research, preclinical studies, product characterization, and GMP manufacturing process development in several platform technologies, including cell and gene therapy, bio-active peptides and recombinant protein with a focus on cancer immunotherapy, angiogenesis, autoimmunity, and inflammatory diseases.
Ted Parenti, Director of Finance, joined AllCells LLC in May 2016. Mr. Parenti brings to AllCells extensive experience in cost accounting, capital investment and budget, and forecast/analysis using ERP systems. Ted has primary responsibility for leading the company’s accounting control, financial reporting, and forecasting processes.
Don is a seasoned technology leader with a long track record of successfully leveraging technology to enable business success and has been a part of the AllCell’s team since early 2016. Don is highly experienced in technology solutions such as: ERP, CRM, E-commerce, Finance, Retail, Marketing and Supply Chain – across multiple vertical industries.